p-Cresyl sulfate promotes insulin resistance associated with CKD

Journal of the American Society of Nephrology

Volumn 24, Issue 1, 2013, Pages 88-99

  Koppe, Laetitia ^a,b   Pillon, Nicolas J ^b   Vella, Roxane E ^b   Croze, Marine L ^b   Pelletier, Caroline C ^a,b   Chambert, Stéphane ^c   Massy, Ziad ^d,f   Glorieux, Griet ^e   Vanholder, Raymond ^e   Dugenet, Yann ^d,f   Soula, H́edi A ^b   Fouque, Denis ^a,b   Soulage, Christophe O ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f Witaxos BioActor Bv BioPartner Center   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 CRESYLSULFATE; ARABINOXYLOOLIGOSACCHARIDE; CHOLESTEROL; GLUCOSE; INSULIN; LIPID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OLIGOSACCHARIDE; PROBENECID; PROBIOTIC AGENT; SULFATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BODY FAT DISTRIBUTION; CHRONIC KIDNEY DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME ACTIVATION; EPIDIDYMIS FAT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY FUNCTION; LIPOGENESIS; LIPOLYSIS; LIVER; METABOLIC DISORDER; MOUSE; MYOTUBE; NONHUMAN; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; SKELETAL MUSCLE; UREMIA; WHITE ADIPOSE TISSUE;

EID: 84871862821     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012050503     Document Type: Article

References (61)

1. Cohen G, Glorieux G, Thornalley P, Schepers E, Meert N, Jankowski J, Jankowski V, Argiles A, Anderstam B, Brunet P, Cerini C, Dou L, Deppisch R, Marescau B, Massy Z, Perna A, Raupachova J, Rodriguez M, Stegmayr B, Vanholder R, Hörl WH; European Uremic Toxin Work Group (EUTox): Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro - towards a standardized approach for research on uraemia. Nephrol Dial Transplant 22: 3381-3390, 2007 (Pubitemid 350212473)
2. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R; Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002 (Pubitemid 35461657)
3. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S; Mexican Nephrology Collaborative Study Group: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13: 1307-1320, 2002 (Pubitemid 34441412)
4. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y: Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int 64: 2238-2243, 2003 (Pubitemid 37449560)
5. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y: Removal of the protein-bound solute p-cresol by convective transport: A randomized crossover study. Am J Kidney Dis 44: 278-285, 2004 (Pubitemid 38962556)
6. Liabeuf S, Drüeke TB, Massy ZA: Protein-bound uremic toxins: new insight from clinical studies. Toxins (Basel) 3: 911-919, 2011
7. De Smet R, Van Kaer J, Van Vlem B, De Cubber A, Brunet P, Lameire N, Vanholder R: Toxicity of free p-cresol: A prospective and cross-sectional analysis. Clin Chem 49: 470-478, 2003 (Pubitemid 36250208)
8. Curtius HC, Mettler M, Ettlinger L: Study of the intestinal tyrosine metabolism using stable isotopes and gas chromatography-mass spectrometry. J Chromatogr A 126: 569-580, 1976
9. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y: Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 69: 1081-1087, 2006 (Pubitemid 43372184)
10. Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E, Temmar M, Choukroun G, Vanholder R, Massy ZA; European Uraemic Toxin Work Group (EUTox): Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 25: 1183-1191, 2010
11. Wu I-W, Hsu K-H, Hsu H-J, Lee C-C, Sun C-Y, Tsai C-J, Wu MS: Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients - a prospective cohort study. Nephrol Dial Transplant 27: 1169-1175, 2012
12. Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, Berland Y, Brunet P: The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 65: 442-451, 2004 (Pubitemid 38130638)
13. Meijers BKI, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P: Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 73: 1174-1180, 2008 (Pubitemid 351620433)
14. Lin C-J, Wu C-J, Pan C-F, Chen Y-C, Sun F-J, Chen H-H: Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients. Nephrol Dial Transplant 25: 3693-3700, 2010
15. Meert N, Schepers E, Glorieux G, Van Landschoot M, Goeman JL, Waterloos M-A, Dhondt A, Van der Eycken J, Vanholder R: Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: Clinical data and pathophysiological implications. Nephrol Dial Transplant 27: 2388-2396, 2012
16. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140, 2005 (Pubitemid 41716445)
17. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J: Insulin resistance in uremia. J Clin Invest 67: 563-568, 1981 (Pubitemid 11141740)
18. DeFronzo RA, Tobin JD, Rowe JW, Andres R: Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 62: 425-435, 1978 (Pubitemid 8393313)
19. Bodlaj G, Berg J, Pichler R, Biesenbach G: Prevalence, severity and predictors of HOMA-estimated insulin resistance in diabetic and nondiabetic patients with end-stage renal disease. J Nephrol 19: 607-612, 2006 (Pubitemid 46415923)
20. Takenaka T, Kanno Y, Ohno Y, Suzuki H: Key role of insulin resistance in vascular injury among hemodialysis patients. Metabolism 56: 153-159, 2007 (Pubitemid 46074059)
21. May RC, Kelly RA, Mitch WE: Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. J Clin Invest 79: 1099-1103, 1987
22. Bailey JL, Zheng B, Hu Z, Price SR, Mitch WE: Chronic kidney disease causes defects in signaling through the insulin receptor substrate/ phosphatidylinositol 3-kinase/Akt pathway: Implications for muscle atrophy. J Am Soc Nephrol 17: 1388-1394, 2006 (Pubitemid 43673419)
23. D'Apolito M, Du X, Zong H, Catucci A, Maiuri L, Trivisano T, Pettoello-Mantovani M, Campanozzi A, Raia V, Pessin JE, Brownlee M, Giardino I: Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest 120: 203-213, 2010
24. Brandenburg VM, Schlieper G, Heussen N, Holzmann S, Busch B, Evenepoel P, Vanholder R, Meijers B, Meert N, Fassbender WJ, Floege J, Jahnen-Dechent W, Ketteler M: Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study. Nephrol Dial Transplant 25: 2672-2679, 2010
25. Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, Hotamisligil GS: Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci U S A 103: 10741-10746, 2006 (Pubitemid 44078046)
26. Bost F, Aouadi M, Caron L, Even P, Belmonte N, Prot M, Dani C, Hofman P, Pagès G, Pouysségur J, Le Marchand-Brustel Y, Binétruy B: The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54: 402-411, 2005
27. DeFronzo RA, Ferrannini E, Sato Y, Felig P, Wahren J: Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest 68: 1468-1474, 1981 (Pubitemid 12194401)
28. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J: Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (type II) diabetesmellitus. J Clin Invest 76: 149-155, 1985 (Pubitemid 15240430)
29. Miyamoto Y, Watanabe H, Noguchi T, Kotani S, Nakajima M, Kadowaki D, Otagiri M, Maruyama T: Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney. Nephrol Dial Transplant 26: 2498-2502, 2011
30. Cloetens L, Broekaert WF, Delaedt Y, Ollevier F, Courtin CM, Delcour JA, Rutgeerts P, Verbeke K: Tolerance of arabinoxylanoligosaccharides and their prebiotic activity in healthy subjects: A randomised, placebo-controlled cross-over study. Br J Nutr 103: 703-713, 2010
31. Lecerf J-M, Dépeint F, Clerc E, Dugenet Y, Niamba CN, Rhazi L, Cayzeele A, Abdelnour G, Jaruga A, Younes H, Jacobs H, Lambrey G, Abdelnour AM, Pouillart PR: Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr 23: 1-12, 2012
32. Runyan JW Jr, Hurwitz D, Robbins SL: Effect of Kimmelstiel-Wilson syndrome on insulin requirements in diabetes. N Engl J Med 252: 388-391, 1955
33. Rabkin R, Simon NM, Steiner S, Colwell JA: Effect of renal disease on renal uptake and excretion of insulin in man. N Engl J Med 282: 182-187, 1970
34. May RC, Clark AS, Goheer MA, Mitch WE: Specific defects in insulin-mediated muscle metabolism in acute uremia. Kidney Int 28: 490-497, 1985 (Pubitemid 15248038)
35. Kraus LM, Traxinger R, Kraus AP: Uremia and insulin resistance: N-carbamoyl-asparagine decreases insulin-sensitive glucose uptake in rat adipocytes. Kidney Int 65: 881-887, 2004 (Pubitemid 38251063)
36. McCaleb ML, Izzo MS, Lockwood DH: Characterization and partial purification of a factor from uremic human serum that induces insulin resistance. J Clin Invest 75: 391-396, 1985 (Pubitemid 15143477)
37. Rigalleau V, Combe C, Blanchetier V, Aubertin J, Aparicio M, Gin H: Low protein diet in uremia: effects on glucose metabolism and energy production rate. Kidney Int 51: 1222-1227, 1997 (Pubitemid 27186550)
38. Okada K, Takahashi Y, Okawa E, Onishi Y, Hagi C, Aoki K, Shibahara H, Higuchi T, Nagura Y, Kanmatsuse K, Takahashi S: Relationship between insulin resistance and uremic toxins in the gastrointestinal tract. Nephron 88: 384-386, 2001 (Pubitemid 32695898)
39. Lin C-J, Chen H-H, Pan C-F, Chuang C-K, Wang T-J, Sun F-J, Wu CJ: p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. J Clin Lab Anal 25: 191-197, 2011
40. Axelsson J, Aström G, Sjölin E, Qureshi AR, Lorente-Cebrián S, Stenvinkel P, Rydén M: Uraemic sera stimulate lipolysis in human adipocytes: role of perilipin. Nephrol Dial Transplant 26: 2485-2491, 2011
41. Kelley DE, Goodpaster BH: Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24: 933-941, 2001 (Pubitemid 33636072)
42. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671, 2004 (Pubitemid 38364625)
43. Itani SI, Ruderman NB, Schmieder F, Boden G: Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-α. Diabetes 51: 2005-2011, 2002 (Pubitemid 34729001)
44. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236, 2002 (Pubitemid 36042170)
45. de Loor H, Meijers BKI, Meyer TW, Bammens B, Verbeke K, Dehaen W, Evenepoel P: Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography. J Chromatogr A 1216: 4684-4688, 2009
46. Meijers BKI, Van Kerckhoven S, Verbeke K, Dehaen W, Vanrenterghem Y, Hoylaerts MF, Evenepoel P: The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 54: 891-901, 2009
47. Tanti J-F, Jager J: Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr Opin Pharmacol 9: 753-762, 2009
48. Ley RE: Obesity and the human microbiome. Curr Opin Gastroenterol 26: 5-11, 2010
49. Broekaert WF, Courtin CM, Verbeke K, Van de Wiele T, Verstraete W, Delcour JA: Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides. Crit Rev Food Sci Nutr 51: 178-194, 2011
50. Nelson RW: Dietary management of diabetes mellitus. J Small Anim Pract 33: 213-217, 1992
51. Diez M, Hornick JL, Baldwin P, Istasse L: Influence of a blend of fructooligosaccharides and sugar beet fiber on nutrient digestibility and plasma metabolite concentrations in healthy beagles. Am J Vet Res 58: 1238-1242, 1997 (Pubitemid 127470905)
52. Meijers BKI, De Preter V, Verbeke K, Vanrenterghem Y, Evenepoel P: p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol Dial Transplant 25: 219-224, 2010
53. Krieter DH, Hackl A, Rodriguez A, Chenine L, Moragues HL, Lemke H-D, Wanner C, Canaud B: Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transplant 25: 212-218, 2010
54. Feigenbaum J, Neuberg C: J Am Chem Soc 63: 3529-3530, 1941
55. Martinez AW, Recht NS, Hostetter TH, Meyer TW: Removal of P-cresol sulfate by hemodialysis. J Am Soc Nephrol 16: 3430-3436, 2005 (Pubitemid 46187553)
56. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE: The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 97: 1447-1453, 1996 (Pubitemid 26097034)
57. Meert N, Eloot S, Schepers E, Lemke H-D, Dhondt A, Glorieux G, Van Landschoot M, Waterloos MA, Vanholder R: Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities. Nephrol Dial Transplant 26: 2624-2630, 2011
58. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509, 1957
59. Etherton TD, Thompson EH, Allen CE: Improved techniques for studies of adipocyte cellularity and metabolism. J Lipid Res 18: 552-557, 1977 (Pubitemid 8149738)
60. Pillon NJ, Croze ML, Vella RE, Soulère L, Lagarde M, Soulage CO: The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces insulin resistance in skeletal muscle through both carbonyl and oxidative stress. Endocrinology 153: 2099-2111, 2012
61. Zarrouki B, Pillon NJ, Kalbacher E, Soula HA, Nia N' Jomen G, Grand L, Chambert S, Geloen A, Soulage CO: Cirsimarin, a potent antilipogenic flavonoid, decreases fat deposition in mice intra-abdominal adipose tissue. Int J Obes (Lond) 34: 1566-1575, 2010